Holen Sie sich die Stockscreener-App
0.2492
9.71%
-0.0268
Schlusskurs vom Vortag:
$0.276
Offen:
$0.28
24-Stunden-Volumen:
1.08M
Relative Volume:
0.80
Marktkapitalisierung:
$50.58M
Einnahmen:
$46.74M
Nettoeinkommen (Verlust:
$-114.33M
KGV:
-0.1932
EPS:
-1.29
Netto-Cashflow:
$-21.04M
1W Leistung:
-19.43%
1M Leistung:
-10.97%
6M Leistung:
-68.85%
1J Leistung:
-82.93%
1-Tages-Spanne:
$0.2492
$0.2821
1-Wochen-Bereich:
$0.2492
$0.34
52-Wochen-Spanne:
$0.21
$2.30
Scilex Holding Company Stock (SCLX) Company Profile
Firmenname
Scilex Holding Company
Sektor
Telefon
(650) 516-4310
Adresse
960 SAN ANTONIO ROAD, PALO ALTO
Vergleichen Sie SCLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SCLX
Scilex Holding Company
|
0.2492 | 50.58M | 46.74M | -114.33M | -21.04M | -1.29 |
|
LLY
Lilly Eli Co
|
852.35 | 765.56B | 45.04B | 10.59B | 414.30M | 11.71 |
|
ABBV
Abbvie Inc
|
201.34 | 355.44B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
161.02 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
NVO
Novo Nordisk Adr
|
73.60 | 334.39B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
MRK
Merck Co Inc
|
87.87 | 235.20B | 64.17B | 17.12B | 18.10B | 6.73 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-27 | Eingeleitet | D. Boral Capital | Buy |
| 2024-10-16 | Eingeleitet | Alliance Global Partners | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-10-16 | Eingeleitet | B. Riley Securities | Buy |
| 2023-10-13 | Eingeleitet | B. Riley Securities | Buy |
| 2023-10-09 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Scilex Holding Company Aktie (SCLX) Neueste Nachrichten
Denali Capital Acquisition Pushes Merger Deadline With Extra Funding -March 12, 2025 at 04:44 am EDT - Marketscreener.com
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination - The Manila Times
Scilex Holding Company Announces Change in Record Date for - GlobeNewswire
Scilex Announces New Record Date for Preferred Stock - TipRanks
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, - The Manila Times
Scilex Holding Company Announces Change of Record Date for Preferred Stock Dividend - Nasdaq
Scilex Holding Ends Sales Agreement with Brokers - TipRanks
Oramed Pharmaceuticals Issues Letter to Shareholders – Company Announcement - Financial Times
Scilex Holding Company (NASDAQ:SCLX) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Breakeven Is Near for Scilex Holding Company (NASDAQ:SCLX) - Yahoo Canada Finance
Scilex Holding ends sales agreement, shares details By Investing.com - Investing.com Australia
Scilex Holding Says Terminates Sales Agreement With B. Riley, Cantor Fitzgerald, H.C. Wainwright Effective March 5 - Marketscreener.com
Scilex Holding ends sales agreement, shares details - Investing.com
Scilex’s (SCLX) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Scilex Pharmaceuticals Inc. Enters into A License Agreement with RoyaltyVest Ltd -February 27, 2025 at 04:05 pm EST - Marketscreener.com
Insider Traders Lose US$193k As Scilex Holding Drops - Simply Wall St
Scilex seeks FDA nod for ELYXYB in acute pain management - MSN
Scilex (NASDAQ:SCLX) Stock Price Down 1.7% – Time to Sell? - Defense World
SCLX Stock Touches 52-Week Low at $0.33 Amid Market Challenges - Investing.com
Merger Deadline Extended: Denali Capital's Strategic Move Backed by Interest-Free $180K Funding - StockTitan
Denali Capital secures extension with Scilex funding - Investing.com
The growth track for Scilex Holding Company (SCLX) has changed recently - SETE News
Analytical Lens: Exploring Scilex Holding Company (SCLX)’s Financial Story Through Ratios - The Dwinnex
D. Boral Capital analysts initates a Buy rating for Scilex Holding Company (SCLX) - Knox Daily
Scilex Holding Company [NASDAQ: SCLX] Sees Decrease in Stock Value - Knox Daily
A company insider recently sold 23,343 shares of Newell Brands Inc [NWL]. Should You Sale? - Knox Daily
Sciatica Treatment Market to Reach at a CAGR 9.7% During - openPR
A company insider recently sold 187,500 shares of Solid Power Inc [SLDP]. Should You Sale? - Knox Daily
SCLX’s Stock Market Adventure: -6.00% YTD Growth Amidst Volatility - The InvestChronicle
Investing in Scilex Holding Company (SCLX) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News
Scilex Dividend Stock lock-up extended to April 14 - MSN
Scilex (NASDAQ:SCLXW) Stock Price Down 4.8% – What’s Next? - Defense World
Investor’s Delight: Scilex Holding Company (SCLX) Closes Weak at 0.41, Down -6.39 - The Dwinnex
UBS Upgrades Rocket Companies Inc (RKT) to a Neutral from a Sell - Knox Daily
Scilex Holding Company (SCLX) rating initates by D. Boral Capital - Knox Daily
Scilex Dividend Stock lock-up extended to April 14 By Investing.com - Investing.com Australia
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025 - The Manila Times
Scilex Holding Company Announces that the U.S. Bankruptcy - GlobeNewswire
Court Mandates 15-Month Extension on Scilex Dividend Stock Trading Restrictions - StockTitan
SCLX stock touches 52-week low at $0.38 amid market challenges - Investing.com
Scilex (NASDAQ:SCLX) Coverage Initiated by Analysts at D. Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Scilex Holding (SCLX) with Buy Recommendation - MSN
This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Holding Company Shares Rally Following Board Of Directors Commentary - MSN
Scilex Holding Faces Financial Strain Amid Form S-3 Ineligibility Crisis - TipRanks
SCLX Beats on Earnings as Product Line Expands - MSN
Scilex FDA submission for ELYXYB acute pain treatment acknowledged - MSN
Scilex Holding Company Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB® in Acute Pain Indication - The Manila Times
Scilex Amends Note Maturity and Cash Sweep Terms - TipRanks
Finanzdaten der Scilex Holding Company-Aktie (SCLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):